{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:02:14Z","timestamp":1774494134817,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T00:00:00Z","timestamp":1741046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Subsidy Funds for Medical Double-high project of Fujian Province","award":["ETK2022009"],"award-info":[{"award-number":["ETK2022009"]}]},{"name":"Medical Double-high project of Fujian province","award":["ETK2022002"],"award-info":[{"award-number":["ETK2022002"]}]},{"name":"Fujian Children's Hospital Cultivation Project","award":["YP202401"],"award-info":[{"award-number":["YP202401"]}]},{"name":"Fujian Province Natural Science Foundation","award":["2022J011061"],"award-info":[{"award-number":["2022J011061"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["2020Y9027"],"award-info":[{"award-number":["2020Y9027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10552-025-01980-x","type":"journal-article","created":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T15:08:46Z","timestamp":1741100926000},"page":"795-802","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Causal relationships between body composition and hematological malignancies: a multivariable mendelian randomization analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Shan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaobin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,4]]},"reference":[{"issue":"1","key":"1980_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao A, Zhou H, Yang J, Li M, Niu T (2023) Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduct Target Ther 8(1):71","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1980_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G et al (2023) Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J 13(1):82","journal-title":"Blood Cancer J"},{"issue":"4","key":"1980_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41375-023-01852-w","volume":"37","author":"K Hemminki","year":"2023","unstructured":"Hemminki K, Hemminki J, F\u00f6rsti A, Sud A (2023) Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment. Leukemia 37(4):854\u2013863","journal-title":"Leukemia"},{"key":"1980_CR4","doi-asserted-by":"crossref","unstructured":"Avgerinos KI, Spyrou N, Mantzoros CS, Dalamaga M. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism: clinical and experimental. 2019;92:121\u201335.","DOI":"10.1016\/j.metabol.2018.11.001"},{"key":"1980_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ebiom.2018.02.022","volume":"30","author":"TW Stone","year":"2018","unstructured":"Stone TW, McPherson M, Gail DL (2018) Obesity and cancer: Existing and new hypotheses for a causal connection. EBioMedicine 30:14\u201328","journal-title":"EBioMedicine"},{"issue":"7","key":"1980_CR6","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/ijc.33697","volume":"149","author":"Q He","year":"2021","unstructured":"He Q, Xia B, Liu A, Li M, Zhou Z, Cheung EC et al (2021) Association of body composition with risk of overall and site-specific cancers: A population-based prospective cohort study. Int J Cancer 149(7):1435\u20131447","journal-title":"Int J Cancer"},{"issue":"8","key":"1980_CR7","doi-asserted-by":"publisher","first-page":"e0202651","DOI":"10.1371\/journal.pone.0202651","volume":"13","author":"H Hagstr\u00f6m","year":"2018","unstructured":"Hagstr\u00f6m H, Andreasson A, Carlsson AC, Jerkeman M, Carlsten M (2018) Body composition measurements and risk of hematological malignancies: A population-based cohort study during 20 years of follow-up. PLoS ONE 13(8):e0202651","journal-title":"PLoS ONE"},{"issue":"15","key":"1980_CR8","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1093\/jnci\/dji209","volume":"97","author":"RJ MacInnis","year":"2005","unstructured":"MacInnis RJ, English DR, Hopper JL, Giles GG (2005) Body size and composition and the risk of lymphohematopoietic malignancies. J Natl Cancer Inst 97(15):1154\u20131157","journal-title":"J Natl Cancer Inst"},{"key":"1980_CR9","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey SG (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical research ed) 362:k601","journal-title":"BMJ (Clinical research ed)"},{"issue":"3","key":"1980_CR10","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J et al (2015) UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med 12(3):e1001779","journal-title":"PLoS Med"},{"issue":"7","key":"1980_CR11","doi-asserted-by":"publisher","first-page":"e1003706","DOI":"10.1371\/journal.pmed.1003706","volume":"18","author":"M Vithayathil","year":"2021","unstructured":"Vithayathil M, Carter P, Kar S, Mason AM, Burgess S, Larsson SC (2021) Body size and composition and risk of site-specific cancers in the UK Biobank and large international consortia: A mendelian randomisation study. PLoS Med 18(7):e1003706","journal-title":"PLoS Med"},{"key":"1980_CR12","first-page":"n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Clinical research ed) 372:n71","journal-title":"BMJ (Clinical research ed)"},{"issue":"6","key":"1980_CR13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S (2017) MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 46(6):1734\u20131739","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1980_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG (2017) Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol 32(5):377\u2013389","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1980_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.3324\/haematol.2019.223925","volume":"105","author":"L Mazzarella","year":"2020","unstructured":"Mazzarella L, Botteri E, Matthews A, Gatti E, Di Salvatore D, Bagnardi V et al (2020) Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism. Haematologica 105(6):1559\u20131566","journal-title":"Haematologica"},{"key":"1980_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.semcancer.2023.04.003","volume":"92","author":"A Tentolouris","year":"2023","unstructured":"Tentolouris A, Ntanasis-Stathopoulos I, Terpos E (2023) Obesity and multiple myeloma: Emerging mechanisms and perspectives. Semin Cancer Biol 92:45\u201360","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"1980_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/1878-0261.12772","volume":"15","author":"CM Friedenreich","year":"2021","unstructured":"Friedenreich CM, Ryder-Burbidge C, McNeil J (2021) Physical activity, obesity and sedentary behavior in cancer etiology: epidemiologic evidence and biologic mechanisms. Mol Oncol 15(3):790\u2013800","journal-title":"Mol Oncol"},{"issue":"11","key":"1980_CR18","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.3390\/cancers12113082","volume":"12","author":"MJ Dushnicky","year":"2020","unstructured":"Dushnicky MJ, Nazarali S, Mir A, Portwine C, Samaan MC (2020) Is there a causal relationship between childhood obesity and acute lymphoblastic leukemia? A review. Cancers 12(11):3082","journal-title":"Cancers"},{"issue":"48","key":"1980_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/jncimonographs\/lgu013","volume":"2014","author":"LM Morton","year":"2014","unstructured":"Morton LM, Slager SL, Cerhan JR, Wang SS, Vajdic CM, Skibola CF et al (2014) Etiologic heterogeneity among non-Hodgkin lymphoma subtypes: the InterLymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr 2014(48):130\u2013144","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"11","key":"1980_CR20","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/bjc.2013.159","volume":"108","author":"F Murphy","year":"2013","unstructured":"Murphy F, Kroll ME, Pirie K, Reeves G, Green J, Beral V (2013) Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study. Br J Cancer 108(11):2390\u20132398","journal-title":"Br J Cancer"},{"issue":"3","key":"1980_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ijc.32753","volume":"147","author":"N Kliemann","year":"2020","unstructured":"Kliemann N, Murphy N, Viallon V, Freisling H, Tsilidis KK, Rinaldi S et al (2020) Predicted basal metabolic rate and cancer risk in the European prospective investigation into cancer and nutrition. Int J Cancer 147(3):648\u2013661","journal-title":"Int J Cancer"},{"issue":"9","key":"1980_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1101\/gad.189365.112","volume":"26","author":"CV Dang","year":"2012","unstructured":"Dang CV (2012) Links between metabolism and cancer. Genes Dev 26(9):877\u2013890","journal-title":"Genes Dev"},{"issue":"12","key":"1980_CR23","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/s41366-021-00942-y","volume":"45","author":"M Ahmed","year":"2021","unstructured":"Ahmed M, Mulugeta A, Lee SH, M\u00e4kinen VP, Boyle T, Hypp\u00f6nen E (2021) Adiposity and cancer: a Mendelian randomization analysis in the UK biobank. Int J Obes 45(12):2657\u20132665","journal-title":"Int J Obes"},{"issue":"6","key":"1980_CR24","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1038\/bcj.2017.48","volume":"7","author":"M Went","year":"2017","unstructured":"Went M, Sud A, Law PJ, Johnson DC, Weinhold N, F\u00f6rsti A et al (2017) Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach. Blood Cancer J 7(6):e573","journal-title":"Blood Cancer J"},{"issue":"11","key":"1980_CR25","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.ejca.2011.01.020","volume":"47","author":"A Wallin","year":"2011","unstructured":"Wallin A, Larsson SC (2011) Body mass index and risk of multiple myeloma: a meta-analysis of prospective studies. Eur J Cancer 47(11):1606\u20131615","journal-title":"Eur J Cancer"},{"issue":"1","key":"1980_CR26","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2020.12.011","volume":"33","author":"Z Li","year":"2021","unstructured":"Li Z, Liu H, He J, Wang Z, Yin Z, You G et al (2021) Acetyl-CoA Synthetase 2: A critical linkage in obesity-induced tumorigenesis in Myeloma. Cell Metab 33(1):78-93.e7","journal-title":"Cell Metab"},{"key":"1980_CR27","doi-asserted-by":"publisher","first-page":"1611338","DOI":"10.3389\/pore.2023.1611338","volume":"29","author":"W Tie","year":"2023","unstructured":"Tie W, Ma T, Yi Z, Liu J, Li Y, Bai J et al (2023) Obesity as a risk factor for multiple myeloma: insight on the role of adipokines. Pathol Oncol Res: POR 29:1611338","journal-title":"Pathol Oncol Res: POR"},{"key":"1980_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.3389\/fendo.2018.00788","volume":"9","author":"D Harmer","year":"2018","unstructured":"Harmer D, Falank C, Reagan MR (2018) Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple Myeloma. Front Endocrinol 9:788","journal-title":"Front Endocrinol"},{"key":"1980_CR29","doi-asserted-by":"publisher","first-page":"148320","DOI":"10.1016\/j.gene.2024.148320","volume":"911","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Zhang X, Li X, Zhu G, Gao T, Deng Y et al (2024) Anthropometric indicators may explain the high incidence of follicular lymphoma in Europeans: Results from a bidirectional two-sample two-step Mendelian randomisation. Gene 911:148320","journal-title":"Gene"},{"key":"1980_CR30","doi-asserted-by":"publisher","first-page":"1400756","DOI":"10.3389\/fimmu.2024.1400756","volume":"15","author":"L Wu","year":"2024","unstructured":"Wu L, Liao F, Guo X, Li N (2024) The causal effect of adipose tissue on Hodgkin\u2019s lymphoma: two-sample Mendelian randomization study and validation. Front Immunol 15:1400756","journal-title":"Front Immunol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-025-01980-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-025-01980-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T07:08:04Z","timestamp":1757142484000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-025-01980-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,4]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["1980"],"URL":"https:\/\/doi.org\/10.1007\/s10552-025-01980-x","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,4]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Since the GWAS data are public, the approval of the ethics committee is not required. The GWAS dataset does not contain identifiable patient information, thus patient' informed consent was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}